Purpose: Infrared light-emitting diodes (IRLEDs) have been used for optic-g
uided stereotactic radiotherapy localization at the University of Florida s
ince 1995, The current paradigm requires stereotactic head ring placement f
or the patient's first fraction. The stereotactic coordinates and treatment
plan are determined relative to this head ring. The IRLEDs are attached to
the patient via a maxillary bite plate, and the position of the IRLEDs rel
ative to linac isocenter is saved to file. These positions are then recalle
d for each subsequent treatment to position the patient for fractionated th
erapy, The purpose of this article was to report a method of predicting the
desired IRLED locations without need for the invasive head ring.
Methods and Materials: To achieve the goal of frameless optic-guided radiot
herapy, a method is required for direct localization of the IRLED positions
from a CT scan. Because it is difficult to localize the exact point of lig
ht emission from a CT scan of an IRLED, a new bite plate was designed that
contains eight aluminum fiducial markers along with the six IRLEDs, After a
calibration procedure to establish the spatial relationship of the IRLEDs
to the aluminum fiducial markers, the stereotactic coordinates of the IRLED
light emission points are determined by localizing the aluminum fiducial m
arkers in a stereotactic CT scan.
Results: To test the accuracy of direct CT determination of the IRLED posit
ions, phantom tests were performed. The average accuracy of isocenter local
ization using the IRLED bite plate was 0.65 +/- 0.17 mm for these phantom t
ests. In addition, the optic-guided system has a unique compatibility with
the stereotactic head ring. Therefore, the isocentric localization capabili
ty was clinically tested using the stereotactic head ring as the absolute s
tandard, The ongoing clinical trial has shown the frameless system to provi
de a patient localization accuracy of 1.11 +/- 0.3 mm compared with the hea
d ring.
Conclusion: Optic-guided radiotherapy using IRLEDs provides a mechanism thr
ough which setup accuracy may be improved over conventional techniques. To
date, this optic-guided therapy has been used only as a hybrid system that
requires use of the stereotactic head ring for the first fraction. This has
limited its use in the routine clinical setting. Computation of the desire
d IRLED positions eliminates the need for the invasive head ring for the fi
rst fraction. This allows application of optic-guided therapy to a larger c
ohort of patients, and also facilitates the initiation of extracranial opti
c-guided radiotherapy, (C) 2000 Elsevier Science Inc.